Lecture 35 - Uterine and ovarian pathology Flashcards

(63 cards)

1
Q

Endometriosis

A

Ectopic endometrium

number of theories behind it - regurgitation theory, metaplasia theory, stem cell theory, metastasis theory

causes bleeding into tissues and then fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Symptoms of endometriosis

A

6-10% of women, 30 - 40 years old

History - 25% asymptomatic, dysmenorrhea, dyspareunia, pelvic pain, subfertility, pain on passing stool, dysuria

Lx : Laparoscopy

Rx : Medical (COCP, GnRH agonists/antagonists, progesterone antagonists) or surgical (ablation/ TAH-BSO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Links to endometriosis

A

Ectopic pregnancy, ovarian cancer, IBD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is endometritis

A

Inflammation of the endometrium

Pelvic inflammatory disease, retained gestational tissue, endometrial TB, IUCD infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Histology of endometritis

A

lymphocytes/plasma cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

History of endometritis

A

Abdominal/pelvic pain, pryrexia, discharge, dysuria, abnormal vaginal bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

examination/testing for endometritis

A

Biochemistry/microbiology, Ultrasound scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Treatment/medication for endometritis

A

Analgesia, antibiotics, remove cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Endometrial polyps

A

Sensile/polypoid E2- dependent uterine overgrowths

< 10% women (40-50’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

History for endometriall polyps

A

often asymptomatic, Intermenstrual/post menopausal bleeding, menorrhagia, dysmenorrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Investigations for endometriall polyps

A

USS, Hysteroscopy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment for endometriall polyps

A

Expectant, medical, (P4/GnRH agonists), surgical (curettage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prognosis for endometriall polyps

A

less than 1% are malignant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Leiomyoma (uterine fibroids)

A

Benign myometrial tumours with E2/P4 dependent growth

  • 20% women 30-50’s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Risk factors for Leiomyoma

A

Genetics, nulliparity, obesity, PCOS, Hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

History for Leiomyoma

A

Often asymptomatic, menometorrhagia, subfertility, pregnancy problems, pressure sx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

investigations for Leiomyoma

A

Bimanusal examination, USS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Treatment for Leiomyoma

A

Medical (IUS,NSAIDs/OCP/P4/FE2+; non-medical (artery embolixation, ablation, TAH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Prognosis for Leiomyoma

A

Menopausal regression, malignancy risk 0.01%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Endometrial hyperplasia

A

excessive endometrial proliferation ( inrease E2, less P4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

risk factors for Endometrial hyperplasia

A

obesity, exogenous E2, PCOS, E2 -producing tumours,tamoxifen, HNPCC ( PTEN mutations)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Types of Endometrial hyperplasia

A

Simple non-atypical, simple atypical

Complex non-atypical, complex atypical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

History of Endometrial hyperplasia

A

Abnormal bleeding - IMB/PCB/PMB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Investigations of Endometrial hyperplasia

A

USS, hysteroscopy +/- biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Treatment for Endometrial hyperplasia
Medical (IUS, P4), surgical (TOTAL ABDOMINAL HYSTERECTOMY)
26
Prognosis for Endometrial hyperplasia
endometrial adenocarcinoma, regression
27
Malignant progression of hyperplasia
Normal - Non-atypical hyperplasia (Resembles normal proliferative endometrium) - Atypical hyperplasia (Presence of cytological abnormality) (EIN - Endometrial Intraepithelial Neoplasia) - Endometroid adenocarcinoma (Invasion into myometrium)
28
Endometrial adenocarcinoma
Most common cancer of female genital tract; 9,200 new cases/ 2.500 deaths/yr UK
29
History of Endometrial adenocarcinoma
Post menopausal bleeding, Intermenstrual bleeding, pain if late
30
Investigations
uss, biopsy, hysteroscopy
31
Staging of Endometrial adenocarcinoma
FIGO (1-4)
32
Treatment of Endometrial adenocarcinoma
``` Medical (progesterone), surgery (TAH - BSO), adjuvant therapy (chemo-radiotherapy) ```
33
Prognosis of Endometrial adenocarcinoma
Stage 1 = 90% 5 year survival | Stage 2-3 = <50%
34
Difference between Type 1 and Type 2 Endometrial adenocarcinoma
Type 1 (endometroid) Type 2 (serous) Incidence -75% of cases 25% of cases Age Pre or perimenopausal Post menopausal Pre-existing state endometrial hyperp Endometrial atrophy Mutations PTEN, Kras p53 e2 state E2, +ve E2 -ve Grades 1,2,3 3
35
PCOS
Endocrine disorder hyperandrogenism, menstrual abnormalities, polycystic ovaries 6-10% women (20-30% have polycystic ovaries)
36
investigations for PCOS
USS, fasting biochemical screen (dropin FSH, increase in LH, increase in testosteron, Increase in Dehydroepiandosterone), oral glucose tolerance test
37
Dx: Diagnosis of PCOS
Rotterdam criteria 2/3 of polycystic ovaries, hyperandrogenism (hirsuitsim/biochemical), irregular periods (over 35 days)
38
treatment for PCOS
Lifestyle - weight loss, medical (metformin, OCP, clomiphene (infertility), surgical (ovarian drilling)
39
Links to PCOS
infertility, endometrial hyperplasia/ adenocarcinoma
40
Gonadal failure
Hypergonadotrophic hypogonadism (primary failure of gonads)
41
Congenital causes of Gonadal failure
Turner's syndrome (XO), Klinefelter's syndrome (XXY)
42
Acquired causes of Gonadal failure
Infection, surgeru, chemo-radiotherapy, toxins/drugs
43
What does secondary failure of gonads result in
Hypogonadotrophic hypogonadism (hypothalamic/pituitary failure) resulting in Sheehan syndrome, pituitary tumours, brain injury PCOS
44
Presentation of gonadal failure
amenorrhoea/absent menarche; delayed puberty. decreased sex hormones, increase LH and FSH levels
45
Investigations for gonadal failure
Hormone profiling, karyotyping
46
Treatment for gonadal failure
Difficult - address cause | Hormone replacement therapy
47
Origin of ovarian neoplasms
Sex cord stromal tumours - granulosa cells, thecomas, fibrothecomas, Sertoli- Leydig cell tumours Germ cell tumours - teratomas, yolk sac tumours, embryonal carcinoma dysgerminomas) Surface epithelial tumours (serous, mucinous, endometroid, transitional cell, clear cell
48
Epithelial tumours
Most common group of ovarian neoplasms (90%) 3 major carcinoma histologic types: Serous (tubal) Mucinous (endocervical) Endometrioid (endometrium) Each type contains benign/ borderline/ malignant variants Benign tumours subclassified based on components; cystic (cystadenomas), fibrous (adenofibromas), cystic and fibrous (cystadenofibromas) Malignant epithelial tumours  cystadenocarcinomas
49
Germ cell tumours
15-20% all ovarian tumours Germinamatous and non -germinamatous
50
Germinamatous tumours
Dysgerminomas (differentiation - oogonia, malignant, chemosensitive)
51
Non- germinamatous tumours
``` Teratomas (differentiation towards multiple germ layers) Most mature (benign; 1% malignant transformation) ``` Yolk sac tumours (differentiation towards extraembryonic yolk sac, malignant, chemosensitive) Choriocarcinomas (differentiation - placenta, malignant, often unresponsive)
52
Treatment for germ cell tumours
surgery with or without chemotherapy
53
Sex cord stromal tumours
Rare; arise from ovarian stroma, which was derived from sex cord embryonic gonad Can generate cells from the opposite sex; Thecoma/ fibrothecoma/ fibroma Benign, thecomas and fibrothecomas produce E2 (also rarely androgens), fibromas hormonally inactive Comprised of spindle cells (plump spindle cells with lipid droplets = thecoma appearance) Meig’s syndrome = ovarian tumour, right sided hydrothorax, ascites Granulosa cell tumours Low grade malignant, produces E2 Sertoli-Leydig cell tumours Produces androgens; 10-25% malignant
54
ovarian cancer
2nd commonest cancer | ; >7,100 women >4,300 deaths/yr UK; 80% >50’s; 80-90% epithelial
55
Risk factors for ovarian cancer
FH, ↑age, PMH breast cancer, smoking, | E2-only HRT, Lynch II syndrome, obesity, nulliparity
56
Protective factors for ovarian cancer
OCP, breastfeeding, hysterectomy
57
History of ovarian cancer
non-specific symptoms; pain, bloating, weight loss, PV bleeding, urinary frequency, anorexia
58
staging of ovarian cancer
FIGO 1-4
59
treatment for ovarian cancer
Stage <1C epithelial tumours  TAH/BSO, omentectomy, appendectomy, lymphadenectomy & adjuvant chemo - chemo only in sensitive GCTs
60
prognosis for ovarian cancer
overall 5 years 43% survival
61
Ovarian metastatic tumours
Mullerian tumours ( most common) and Non-Mullerian tumours
62
Mullerian tumours
uterus, fallopian tube, pelvic peritoneum, contralateral ovary
63
Non-Müllerian tumours
Lymphatic/ haematogenous spread: GI tract: Large bowel, stomach (Krukenberg tumour), pancreatobiliary ``` Breast Melanoma Less commonly, kidney and lung Direct extension: bladder, rectal Metastatic tumours are confirmed histologically; prognosis is typically poor ```